Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NPS Gattex Wins Approval for Short-Bowel Syndrome
Bloomberg
Saturday, December 22, 2012 - 12:19pm
tags:
Gattex, short bowel syndrome, NPS Pharmaceuticals
Halozyme Jumps Most in Six Years on Pfizer Partnership
Bloomberg
Saturday, December 22, 2012 - 12:17pm
tags:
Halozyme, Pfizer
Gilead A Strong Buy On New HIV Treatments
Motley Fool
Saturday, December 22, 2012 - 12:16pm
tags:
Gilead, HIV, Stribild
Long Mannkind? How To Make Money While In Queue
Seeking Alpha
Saturday, December 22, 2012 - 12:15pm
tags:
MannKind
Transcept caps a tough year with PhII drug failure
Fierce Biotech
Friday, December 21, 2012 - 10:56am
tags:
Transcept, TO-2061, OCD
5 Drug Hopefuls That Are Going to Change Your Life: Part 5
Motley Fool
Friday, December 21, 2012 - 10:54am
tags:
LAMA/LABA, GSK, Theravance, COPD
Cubist Submits ENTEREG Supplemental NDA
Yahoo
Friday, December 21, 2012 - 10:52am
tags:
Entereg, Cubist Pharmaceuticals, bowel resection
3 Things to Watch at Isis Pharmaceuticals
Motley Fool
Friday, December 21, 2012 - 10:49am
tags:
Isis Pharmaceuticals, Kynamro
Medicines Co skin infection antibiotic meets trial goal
Reuters
Friday, December 21, 2012 - 10:46am
tags:
antibiotics, Medicines Company, Solo-1
Teva's New Focused Corporate Strategy Is Just What The Doctor Ordered
Seeking Alpha
Friday, December 21, 2012 - 10:45am
tags:
Teva
Smaller players looking for expansion deals, too
Fierce Pharma
Friday, December 21, 2012 - 10:45am
tags:
M&A, Stallergenes
How will pharma fare in 2013? It's complicated
Fierce Pharma
Friday, December 21, 2012 - 10:44am
tags:
pharma industry
Pfizer Pays $1M For Violating Deal With Oregon
Pharmalot
Friday, December 21, 2012 - 10:43am
tags:
Pfizer, settlements, Oregon, drug ads
Potentially game changing data awaits Acorda in 2013
Reuters
Friday, December 21, 2012 - 10:42am
tags:
Acorda Therapeutics, AMPYRA, stroke
Horizon Pharma gets UK nod for arthritis drug
Yahoo/AP
Friday, December 21, 2012 - 10:40am
tags:
Horizon Pharma, UK, Duexis, osteoarthritis, rheumatoid arthritis
4 Biotech Names With Major Market Potential: Michael Higgins
Seeking Alpha
Friday, December 21, 2012 - 10:26am
tags:
BioDelivery Sciences, MannKind, Akorn
Vivus Rises On Wider Coverage Of Qsymia
Seeking Alpha
Friday, December 21, 2012 - 10:25am
tags:
Qsymia, Vivus, obesity
Halozyme Shares Jump on Pfizer Development Deal
Bloomberg
Friday, December 21, 2012 - 10:23am
tags:
Halozyme, Pfizer, injectables, drug delivery
Inside the New Abbott: A Lot Like the Old Abbott But Without Humira
Motley Fool
Friday, December 21, 2012 - 10:16am
tags:
Abbott, AbbVie, Humira
Merck’s Tredaptive Is Under Review by EU Regulator
Bloomberg
Friday, December 21, 2012 - 10:16am
tags:
Merck, Europe, Tredaptive

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.